ChartFu appears to trade like a focused position trader rather than a high-frequency wallet. Over the last 30 days, this wallet made 17 trades across 5 unique tokens, with an average holding time of 2078360 seconds. That points to a selective style with relatively concentrated exposure instead of broad rotation. The activity profile suggests ChartFu is willing to sit in positions and let outcomes develop, but the narrow token count also means results can be heavily influenced by just a few names.
Recent performance was weak. In the last 30 days, ChartFu posted -501.32 in PnL with ROI of -50.92%. Total buys came to 984.56, while total sells reached 385.21, showing a sizable gap between capital deployed and capital realized back out. The wallet’s win rate was 20%, which is low for a set of only 17 trades and suggests that most positions closed at a loss. With only 5 tokens traded, the negative result was not caused by overtrading, but by poor outcomes in a concentrated book.
The token-level breakdown shows a limited number of offsets against several meaningful losses. The best result came from BTKf… at 285.3 in PnL across 2 trades. That gain was more than erased by the worst performer, 9Q56…, which lost -357.23 across 3 trades. GfjJ… also weighed heavily on results with -290.15 across 6 trades, making it one of the biggest drags in both frequency and dollars. The remaining names, ATXj… at -80.34 across 2 trades and 2bLd… at -58.9 across 4 trades, added smaller but still material losses. Overall, one winner was not enough to overcome repeated drawdowns elsewhere.
This wallet is most relevant to traders who specifically want to follow a focused, slower-moving Solana wallet that holds positions for longer periods and accepts concentration risk. It may appeal more to copy traders who prefer fewer names and lower trade count over constant activity. At the same time, the recent record shows weak execution, a 20% win rate, and heavy dependence on a small number of positions, so anyone evaluating ChartFu should be comfortable with uneven outcomes and significant downside in a short sample.